Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. The midterms are here. My colleagues will be closely tracking the elections and their implications on health policy, so check back in for our coverage. We also have a helpful primer here.
The need-to-know this morning
- Pfizer earnings. Madrigal Pharma earnings. Alkermes earnings. BioNTech earnings.
- Vertex Pharma reported earnings on Monday night, as did Neurocrine Biosciences.
Who will get the first psychedelic approved?
The biotech Compass Pathways has been seen as one of the frontrunners in the race to get the first psychedelic drug approved. But it could be a tight race, with a non-profit organization closing in on its own efforts.
Continue to STAT+ to read the full story…
